[Skip to Content]
[Skip to Content Landing]

August 2019 - January 1920

Decade

Year

Issue

September 2015, Vol 151, No. 9, Pages 919-1044

In This Issue of JAMA Dermatology

Highlights

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):919. doi:10.1001/jamadermatol.2014.2936
Viewpoint

The Reach of the 340B Drug Pricing Program

Abstract Full Text
JAMA Dermatol. 2015;151(9):923-924. doi:10.1001/jamadermatol.2015.1005

This Viewpoint discusses the 304B drug pricing program and how institutions can use the program to make medications available to uninsured patients.

Editorial

Potential Synergy of Radiation Therapy With Vismodegib for Basal Cell Carcinoma

Abstract Full Text
JAMA Dermatol. 2015;151(9):925-926. doi:10.1001/jamadermatol.2015.0977

K+larity for Spironolactone: At Last!

Abstract Full Text
JAMA Dermatol. 2015;151(9):926-927. doi:10.1001/jamadermatol.2015.35
Original Investigation

Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):941-944. doi:10.1001/jamadermatol.2015.34

This retrospective study finds that the rate of hyperkalemia in healthy young women taking spironolactone for acne is equivalent to the baseline rate of hyperkalemia in this population. See the Editorial by Graber.

Comparison of Efficacy of Differing Partner-Assisted Skin Examination Interventions for Melanoma Patients: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):945-951. doi:10.1001/jamadermatol.2015.0690

This randomized clinical trial observes the efficacy of interventions used for skin self-examination in patients with a history of melanoma.

Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):952-960. doi:10.1001/jamadermatol.2015.0502

In this randomized clinical trial evaluating the long-term efficacy of a single course of fluorouracil cream, 5%, for treating actinic keratoses, Pomerantz et al found that this treatment effectively reduces actinic keratosis counts and the need for spot treatments for longer than 2 years.

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):961-969. doi:10.1001/jamadermatol.2015.0718

This multicenter, intercontinental, longitudinal, disease-based registry study at dermatology centers determines the effect of biologic and systemic treatment on the risk of serious infections in patients with psoriasis.

Effect of Automated Online Counseling on Clinical Outcomes and Quality of Life Among Adolescents With Acne Vulgaris: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):970-975. doi:10.1001/jamadermatol.2015.0859

This randomized clinical trial determines that, although Internet-based acne education using automated counseling is not superior to standard-website education in improving acne severity and quality of life among adolescents, a greater proportion of participants who viewed the automated-counseling website reported having maintained or adopted a recommended anti-acne skin care regimen.

Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012

Abstract Full Text
free access has audio
JAMA Dermatol. 2015;151(9):976-981. doi:10.1001/jamadermatol.2015.1188

This retrospective cohort study provides an updated estimate of basal cell carcinoma incidence, highlights the changing epidemiologic findings, and better identifies demographically distinct high-risk subgroups.

Sun Protection and Skin Examination Practices in a Setting of High Ambient Solar Radiation: A Population-Based Cohort Study

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):982-990. doi:10.1001/jamadermatol.2015.0739

This prospective cohort study found that sun protection and skin examination practices were most frequent among those with a history of treated skin lesions or sun-sensitive skin types.

Factors Associated With Occupational Sun-Protection Policies in Local Government Organizations in Colorado

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):991-997. doi:10.1001/jamadermatol.2015.0575

This report of baseline survey data from a randomized pretest-posttest controlled experiment determines that local government organizations might integrate sun-safety policies into existing workplace safety procedures in local government organizations in Colorado.

Case Report/Case Series

Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):998-1001. doi:10.1001/jamadermatol.2015.0326

On the basis of 2 case reports, the combination of vismodegib and radiotherapy is feasible for patients with recurrent or locally advanced basal cell carcinoma.

Local Recurrence and Ocular Adnexal Complications Following Electronic Surface Brachytherapy for Basal Cell Carcinoma of the Lower Eyelid

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):1002-1004. doi:10.1001/jamadermatol.2015.2613

This case report presents complications in a man with a recurrent basal cell carcinoma within the radiation field 10 months after undergoing electronic surface brachytherapy for a biopsy-proven basal cell carcinoma.

Review

Comparison of Dermatology and Allergy Guidelines for Atopic Dermatitis Management

Abstract Full Text
JAMA Dermatol. 2015;151(9):1009-1013. doi:10.1001/jamadermatol.2015.0250

This review compared the guidelines for management of atopic dermatitis from several specialty organizations and found notable differences in some treatment recommendations among the guidelines.

JAMA Dermatology Clinical Evidence Synopsis

Screening Recommendations for Chlamydia and Gonorrhea

Abstract Full Text
JAMA Dermatol. 2015;151(9):1014-1016. doi:10.1001/jamadermatol.2015.1987

This Clinical Evidence Synopsis summarizes the most recent guidelines on screening men and women for chlamydia and gonorrhea.

JAMA Dermatology Clinicopathological Challenge

Asymptomatic Papular Eruption in a Teenage Boy

Abstract Full Text
JAMA Dermatol. 2015;151(9):1019-1020. doi:10.1001/jamadermatol.2015.1432

Immediate Pigmentation After Laser Treatment

Abstract Full Text
JAMA Dermatol. 2015;151(9):1021-1022. doi:10.1001/jamadermatol.2015.1569

Creamy Yellow Concretions in Axillary Hair

Abstract Full Text
JAMA Dermatol. 2015;151(9):1023-1024. doi:10.1001/jamadermatol.2015.0989
Research Letter

Topically Applied Midodrine, 0.2%, an α1-Agonist, for the Treatment of Erythromelalgia

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):1025-1026. doi:10.1001/jamadermatol.2015.0511

This before-after study reports that midodrine, 0.2%, is well tolerated and improves symptoms associated with erythromelalgia.

Minocycline for Recurrent and/or Chronic Erythema Nodosum Leprosum

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):1026-1028. doi:10.1001/jamadermatol.2015.0384

Assessment of Consumer Knowledge of New Sunscreen Labels

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):1028-1030. doi:10.1001/jamadermatol.2015.1253

Efficacy of Vinblastine in Primary Cutaneous Anaplastic Large Cell Lymphoma

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):1030-1031. doi:10.1001/jamadermatol.2015.1357

This retrospective study of patients with cutaneous anaplastic large cell lymphoma reports the efficacy of vinblastine as monotherapy for this condition.

Observation

Practical Events in the Management of a Collodion Baby

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):1031-1032. doi:10.1001/jamadermatol.2015.0694

Oral Acyclovir and Intralesional Interferon Injections for Treatment of Giant Pyogenic Granuloma–Like Lesions in an Immunocompromised Patient With Human Orf

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):1032-1034. doi:10.1001/jamadermatol.2015.0760

This case report describes the successful use of oral acyclovir and intralesional interferon injections to treat giant pyogenic granuloma–like lesions in an immunocompromised patient with human orf.

Ex Vivo Fluorescence Confocal Microscopy of Eccrine Syringomatous Carcinoma: A Report of 2 Cases

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):1034-1036. doi:10.1001/jamadermatol.2015.1008
Comment & Response

Radiation Oncologist Concerns About Increased Electronic Brachytherapy Use for Skin Cancer

Abstract Full Text
JAMA Dermatol. 2015;151(9):1036. doi:10.1001/jamadermatol.2015.2006

The 2-Step Method and the Recognition Process in Dermoscopy

Abstract Full Text
JAMA Dermatol. 2015;151(9):1037-1038. doi:10.1001/jamadermatol.2015.2000

Radiation Oncologist Concerns About Increased Electronic Brachytherapy Use for Skin Cancer—Reply

Abstract Full Text
JAMA Dermatol. 2015;151(9):1037. doi:10.1001/jamadermatol.2015.2007
Correction

Incorrect Information in Figure

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):1038. doi:10.1001/jamadermatol.2015.3058
Notable Notes

Pellagra’s Three Ds: Dermatology, Death, and Dracula

Abstract Full Text
JAMA Dermatol. 2015;151(9):951. doi:10.1001/jamadermatol.2015.1358

Of Steinbeck and Sunburn

Abstract Full Text
JAMA Dermatol. 2015;151(9):960. doi:10.1001/jamadermatol.2015.1664

19th Century Dermatologic Atlases in the Early Age of Photography

Abstract Full Text
JAMA Dermatol. 2015;151(9):969. doi:10.1001/jamadermatol.2015.1509

The Snark and the Skin: Jack London’s Pacific Voyage

Abstract Full Text
JAMA Dermatol. 2015;151(9):1016. doi:10.1001/jamadermatol.2014.2890
JAMA Dermatology Patient Page

Venous Ulcers

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):1044. doi:10.1001/jamadermatol.2015.58
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2015;151(9):920. doi:10.1001/jamadermatol.2014.2937
×